Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 1,830 | 1,849 | 1,782 | 1,810 | -28 | -1.5% | 79,700 |
2020/08/11 | 1,770 | 1,840 | 1,744 | 1,838 | +77 | +4.4% | 92,100 |
2020/08/07 | 1,708 | 1,784 | 1,708 | 1,761 | +53 | +3.1% | 82,900 |
2020/08/06 | 1,847 | 1,847 | 1,703 | 1,708 | -107 | -5.9% | 161,600 |
2020/08/05 | 1,805 | 1,846 | 1,766 | 1,815 | +12 | +0.7% | 89,400 |
2020/08/04 | 1,735 | 1,827 | 1,730 | 1,803 | +86 | +5% | 120,600 |
2020/08/03 | 1,626 | 1,744 | 1,625 | 1,717 | +91 | +5.6% | 82,400 |
2020/07/31 | 1,678 | 1,735 | 1,616 | 1,626 | -61 | -3.6% | 119,100 |
2020/07/30 | 1,679 | 1,699 | 1,609 | 1,687 | +19 | +1.1% | 71,400 |
2020/07/29 | 1,648 | 1,692 | 1,615 | 1,668 | +42 | +2.6% | 101,700 |
2020/07/28 | 1,654 | 1,694 | 1,550 | 1,626 | -21 | -1.3% | 240,700 |
2020/07/27 | 1,757 | 1,760 | 1,641 | 1,647 | -124 | -7% | 142,100 |
2020/07/22 | 1,680 | 1,805 | 1,668 | 1,771 | +86 | +5.1% | 201,500 |
2020/07/21 | 1,643 | 1,705 | 1,633 | 1,685 | +25 | +1.5% | 116,900 |
2020/07/20 | 1,573 | 1,660 | 1,554 | 1,660 | +93 | +5.9% | 157,100 |
2020/07/17 | 1,756 | 1,764 | 1,563 | 1,567 | -193 | -11% | 377,900 |
2020/07/16 | 1,819 | 1,860 | 1,744 | 1,760 | -78 | -4.2% | 126,800 |
2020/07/15 | 1,800 | 1,865 | 1,765 | 1,838 | +56 | +3.1% | 155,400 |
2020/07/14 | 1,851 | 1,930 | 1,779 | 1,782 | -72 | -3.9% | 332,800 |
2020/07/13 | 2,183 | 2,200 | 1,853 | 1,854 | -298 | -13.8% | 944,900 |
2020/07/10 | 1,775 | 2,152 | 1,773 | 2,152 | +400 | +22.8% | 127,500 |
2020/07/09 | 1,895 | 1,901 | 1,707 | 1,752 | -172 | -8.9% | 386,000 |
2020/07/08 | 1,857 | 1,945 | 1,820 | 1,924 | +107 | +5.9% | 241,800 |
2020/07/07 | 1,987 | 2,018 | 1,765 | 1,817 | -215 | -10.6% | 911,300 |
2020/07/06 | 2,126 | 2,126 | 1,961 | 2,032 | -109 | -5.1% | 222,700 |
2020/07/03 | 2,017 | 2,180 | 2,017 | 2,141 | +74 | +3.6% | 140,500 |
2020/07/02 | 2,158 | 2,180 | 1,961 | 2,067 | -135 | -6.1% | 340,200 |
2020/07/01 | 2,325 | 2,341 | 2,180 | 2,202 | -87 | -3.8% | 128,100 |
2020/06/30 | 2,400 | 2,405 | 2,105 | 2,289 | -41 | -1.8% | 234,000 |
2020/06/29 | 2,430 | 2,503 | 2,310 | 2,330 | -180 | -7.2% | 255,600 |
2020/06/26 | 2,652 | 2,670 | 2,508 | 2,510 | -65 | -2.5% | 254,400 |
2020/06/25 | 2,570 | 2,635 | 2,489 | 2,575 | ±0 | ±0% | 201,800 |
2020/06/24 | 2,480 | 2,628 | 2,440 | 2,575 | +137 | +5.6% | 299,300 |
2020/06/23 | 2,652 | 2,699 | 2,400 | 2,438 | -50 | -2% | 447,900 |
2020/06/22 | 2,307 | 2,500 | 2,273 | 2,488 | +159 | +6.8% | 250,900 |
2020/06/19 | 2,252 | 2,335 | 2,215 | 2,329 | +77 | +3.4% | 157,700 |
2020/06/18 | 2,250 | 2,252 | 2,100 | 2,252 | -29 | -1.3% | 251,600 |
2020/06/17 | 2,343 | 2,343 | 2,222 | 2,281 | -17 | -0.7% | 246,600 |
2020/06/16 | 2,171 | 2,387 | 2,160 | 2,298 | +277 | +13.7% | 460,900 |
2020/06/15 | 2,332 | 2,340 | 1,933 | 2,021 | -261 | -11.4% | 650,100 |
2020/06/12 | 2,271 | 2,453 | 2,192 | 2,282 | -189 | -7.6% | 548,700 |
2020/06/11 | 2,455 | 2,624 | 2,321 | 2,471 | +18 | +0.7% | 740,600 |
2020/06/10 | 2,297 | 2,550 | 2,296 | 2,453 | +113 | +4.8% | 517,100 |
2020/06/09 | 2,280 | 2,345 | 2,205 | 2,340 | +26 | +1.1% | 325,600 |
2020/06/08 | 2,287 | 2,344 | 2,260 | 2,314 | +33 | +1.4% | 290,800 |
2020/06/05 | 2,207 | 2,288 | 2,185 | 2,281 | +29 | +1.3% | 370,800 |
2020/06/04 | 2,258 | 2,405 | 2,232 | 2,252 | -84 | -3.6% | 1,026,600 |
2020/06/03 | 2,215 | 2,479 | 2,111 | 2,336 | +75 | +3.3% | 2,047,500 |
2020/06/02 | 2,171 | 2,261 | 2,090 | 2,261 | +400 | +21.5% | 1,176,100 |
2020/06/01 | 1,826 | 1,936 | 1,782 | 1,861 | +103 | +5.9% | 530,300 |
1051~
1100
件表示中 / 1492件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 51,900円 | - | - | 0.00% | - | 14.89倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入iPS由来細胞医薬や抗体医薬開発に注力 |
免疫生物 | 50,000円 | +13.4% | -4.0% | 0.00% | 40.49倍 | 3.49倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
ファンペップ | 14,000円 | - | - | 0.00% | - | 2.12倍 |
|
大阪大医研発。患者の体内で抗体の産生を誘導する抗体誘導ペプチドを用いた医薬品を開発 |
市場注目の銘柄
チャート関連のコラム